Michael A. Berman
Chief Executive Officer at Michael A. Berman Group, Inc.
Profile
Michael A.
Berman is currently the President & Chief Executive Officer of Dr. Berman Group, Inc. and the Chairman of US Invest Group, Inc. He was previously the Director & Executive Vice President of NewYork-Presbyterian Hospital from 1997 to 2005 and an Independent Director of Mallinckrodt Hospital Products, Inc. from 2011 to 2013.
Berman holds a doctorate degree from SUNY Upstate Medical University.
Michael A. Berman active positions
| Companies | Position | Start |
|---|---|---|
| Michael A. Berman Group, Inc. | Chief Executive Officer | 01/01/2005 |
US Invest Group, Inc.
 US Invest Group, Inc. Investment Banks/BrokersFinance US Invest Group, Inc. provides investment services. The firm’s invest in healthcare and technology ventures in China and develop the opportunities into competitive and valuable businesses. The company is headquartered in Palo Alto, CA. | Chairman | 01/01/2005 |
Former positions of Michael A. Berman
| Companies | Position | End |
|---|---|---|
| CADENCE PHARMACEUTICALS, INC. | Director/Board Member | 12/06/2013 |
NewYork-Presbyterian Hospital
 NewYork-Presbyterian Hospital Hospital/Nursing ManagementHealth Services NewYork-Presbyterian Hospital offers healthcare services. Its services include surgery, corporate health, nephrology, dermatology, cardiology, hepatology, vascular care, emergency care, and ambulatory care. The company was founded in 1771 and is headquartered in New York, NY. | Director/Board Member | 01/01/2005 |
Training of Michael A. Berman
| SUNY Upstate Medical University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
| Michael A. Berman Group, Inc. | |
NewYork-Presbyterian Hospital
NewYork-Presbyterian Hospital Hospital/Nursing ManagementHealth Services NewYork-Presbyterian Hospital offers healthcare services. Its services include surgery, corporate health, nephrology, dermatology, cardiology, hepatology, vascular care, emergency care, and ambulatory care. The company was founded in 1771 and is headquartered in New York, NY. | Health Services |
US Invest Group, Inc.
US Invest Group, Inc. Investment Banks/BrokersFinance US Invest Group, Inc. provides investment services. The firm’s invest in healthcare and technology ventures in China and develop the opportunities into competitive and valuable businesses. The company is headquartered in Palo Alto, CA. | Finance |
- Stock Market
- Insiders
- Michael A. Berman
